For Natural Wound Healing.

EmaCure® is a next-generation, blood-derived therapeutic system based on research carried out at the Technische Universität München. Using this system, clinicians can develop personalised therapies to meet their patients' needs in the areas of wound repair and regeneration.

Network

Contact

info@emacure.org

 

News

Feb. 2017 B. Braun Melsungen AG develops EmaCure technology for clinical application

 

Sept. 2016 EmaCure presented at the DGPRÄC Congress in Kassel

 

March 2016 EmaCure wins Science4Life Award

 

Oct. 2015  EmaCure presented at the DGPRÄC Congress in Berlin

 

May 2015 EmaCure presented at the 60th PSRC Meeting in Seattle

 

Sept. 2014  EmaCure presented at the DGPRÄC / VDÄPC /ÖGPÄRC Congress in Munich

 

May 2014  EmaCure presented at the 3rd EURAPS Research Counsil Meeting in Ischia, winning award for best scientific work

 

March 2014  EmaCure is awarded the TUM IdeAward 2014 for best scientific  idea with market potential

 

Nov. 2013 Prof.A.F.Schilling to present EmaCure at TUM-IAS, Scientists meet Scientists (20.11.13 at 13.15pm)

 

Oct. 2013 EmaCure presented at the 1st Wund-D.A.CH 3-country Congress in Friedrichshafen, winning the Prize for best scientific work (awarded to Mr P.Moog).

 

Aug. 2013 Publication of international patent application on a device for preparing and delivering the EmaCure therapy.

 

May 2013 Prof. A.F.Schilling and Dr E.Hadjipanayi are awarded the Innovation Prize for their work on the EmaCure therapy, at the German Symposium for Biotechnology (Deutsche Biotechnologietage) in Stuttgart

 

May 2013 EmaCure presented at the International Investigative Dermatology (IID) Congress 2013 in Edinburgh

 

April 2013  ESDR (European Society for Dermatological Research) Grant awarded to Mrs. A.T.Bauer for her participation in the IID (International Investigative Dermatology) Congress 2013 in Edinburgh.

 

March 2013 EmaCure presented at the 17th World Congress of the International Confederation for  Plastic, Reconstructive and Aesthetic Surgery (IPRAS) in Santiago

 

Feb.2013 International patent  (PCT) application filed on a device for preparing and delivering the EmaCure therapy

 

Nov. 2012 Scientists working on the EmaCure therapy receive Best Paper Award at the IPRAS-TA/10th IQUAM Congress and Consensus Conference in Athens

 

Sept. 2012 EmaCure presented at the 3rd World Congress of Tissue Engineering and Regenerative Medicine (TERMIS) in Vienna

 

Druckversion | Sitemap
© EmaCure